Bristol Myers (BMY) Squibb announced that its Board of Directors has declared a quarterly dividend of 63c per share on the $0.10 par value common stock of the company. The dividend is payable on February 2, 2026, to stockholders of record at the close of business on January 2, 2026. This quarterly dividend represents a 1.6% increase over last year’s quarterly rate of 62c per share. At this quarterly dividend rate, subject to the normal quarterly review by the Board of Directors, the annual dividend rate for the fiscal year 2026 is $2.52 per share. This marks the 17th consecutive year that the company has increased its dividend and the 94th consecutive year that the company has paid a dividend.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMY:
- Bristol Myers price target raised to $53 from $50 at HSBC
- Trump Weekly: President approves U.S. manufacturing of ‘tiny cars’
- Bristol Myers’ Breyanzi approved by FDA as CAR-T therapy for MZL
- FDA shift in drug study requirements sends trial runners lower
- FDA to reduce number of trials required for drug approvals, STAT reports